What is the recommended regimen for correcting acute symptomatic hyponatraemia in an adult using hypertonic (3%) saline?

Sodium Correction Using Hypertonic Saline

For acute symptomatic hyponatremia in adults, administer 3% hypertonic saline as 100-150 mL boluses to correct sodium by 6 mmol/L over 6 hours or until severe symptoms resolve, with a maximum total correction of 8 mmol/L in the first 24 hours. 1

Initial Assessment and Severity Classification

Determine symptom severity to guide treatment intensity:

Severe symptoms (requiring ICU admission with Q2hr sodium monitoring):

• Mental status changes
• Seizures
• Coma
• Cardiorespiratory distress

Mild symptoms (intermediate care with Q4hr monitoring):

• Nausea/vomiting
• Headache
• Confusion without altered consciousness

Treatment Protocol for Severe Symptomatic Hyponatremia

Hypertonic Saline Administration

Initial bolus approach:

• Give 100-150 mL of 3% NaCl as IV bolus 1
• Target: Increase sodium by 6 mmol/L over 6 hours OR until severe symptoms resolve
• Critical safety limit: Do not exceed 8 mmol/L total correction in first 24 hours 1

Dosing calculation:

• Sodium deficit = Desired increase (mEq) × (0.5 × ideal body weight in kg) 1
• This conservative formula accounts for distribution in total body water

Monitoring and Repeat Dosing

Important caveat: Real-world data shows 22.6% of patients exceed target rise after just one bolus 2. Consider checking sodium before administering the second bolus unless severe symptoms persist 2, 3. Venous blood gas sodium can provide rapid point-of-care results, though it typically reads 1.9 mmol/L lower than serum sodium 2.

Frequency of monitoring:

• Q2hr sodium checks during active correction 1
• Daily weights and strict intake/output monitoring
• Adjust or stop 3% NaCl when severe symptoms resolve 1

Critical Correction Limits

The 6-2 rule 1:

• If you correct 6 mmol/L in the first 6 hours, you can only increase sodium by an additional 2 mmol/L over the remaining 18 hours
• This prevents exceeding the 8 mmol/L/24-hour safety threshold

Subsequent 24-hour period:

• Maximum correction of 8 mmol/L in second 24 hours (total 18 mmol/L over 48 hours) 1

Special Considerations

Acute vs. Chronic Hyponatremia

Rapid correction (>1 mmol/L/hour) should be reserved exclusively for:

• Severely symptomatic patients
• Acute hyponatremia (<48 hours duration) 1

Chronic hyponatremia (>48 hours) carries significant risk of osmotic demyelination syndrome with rapid correction 1. The brain has adapted by losing solutes, making it vulnerable to rapid osmotic shifts. Target slower correction rates of 4-6 mmol/L per 24 hours in chronic cases 4.

Overcorrection Prevention

Real-world studies reveal concerning overcorrection rates of 19.6-44.9% at 24-48 hours using current guidelines 5, 2. Proactive desmopressin (DDAVP clamp) co-administered with hypertonic saline from treatment initiation significantly reduces overcorrection risk (0% vs 15% exceeding 10 mmol/L at 24 hours) without increasing adverse events 6.

If overcorrection occurs:

• Administer 5% dextrose (preferred by 75.9% of UK endocrinologists) 3
• Consider desmopressin for relowering 4, 3
• Goal: Prevent osmotic demyelination syndrome, which presents 2-7 days post-correction with dysarthria, dysphagia, and quadriparesis 4

High-Risk Populations

Patients at increased overcorrection risk 7, 5:

• Body weight ≤60 kg (fixed dosing causes disproportionate correction)
• Volume depletion (high urine output correlates with overcorrection)
• Hypokalemia
• Lower baseline sodium levels

Patients at increased ODS risk 4:

• Advanced liver disease
• Alcoholism
• Malnutrition
• Severe metabolic derangements (hypophosphatemia, hypokalemia)

Route of Administration

Administer through large vein for rapid dilution given the hypertonic nature (1,027 mOsmol/L osmolarity) 8. Do not use vented IV sets with flexible containers due to air embolism risk 8. Never mix with whole blood or cellular blood components 8.

Transition to Maintenance Therapy

Once severe symptoms resolve:

• Transition to mild symptom protocol or asymptomatic management 1
• Continue treatment until sodium reaches 131 mmol/L 1
• For SIADH: Implement fluid restriction (1L/day), consider oral salt supplementation (100 mEq TID), high-protein diet 1

Common Pitfalls

Misinterpreting hypovolemic symptoms as severe hyponatremia: Patients with volume depletion may present with confusion or weakness that improves with isotonic saline alone. High urine output during treatment suggests hypovolemia was the primary issue 5.

Using continuous infusions instead of boluses: While 9.8% of clinicians use continuous infusions 3, bolus administration is preferred for symptomatic hyponatremia as it allows better control and monitoring 9, 10.

Inadequate monitoring frequency: Checking sodium less frequently than Q2hr during active correction increases overcorrection risk, particularly after the second bolus when 34.6% exceed target 5.